Effects of Xiaoyaosan on Depressive-Like Behaviors in Rats With Chronic Unpredictable Mild Stress Through HPA Axis Induced Astrocytic Activities

Ming Song,Jianjun Zhang,Xiaojuan Li,Yueyun Liu,Tingye Wang,Zhiyi Yan,Jiaxu Chen
DOI: https://doi.org/10.3389/fpsyt.2020.545823
IF: 4.7
2020-10-20
Frontiers in Psychiatry
Abstract:<span> Astrocytes in the hippocampus are immediately relevant to depressive-like behavior. By regulating their activities, Xiaoyaosan (XYS), a traditional Chinese medicine compound, works in the treatment of depression.<strong>Objective:</strong> Chronic unpredictable mild stress (CUMS) rat model was established to observe the regulation of XYS. We investigated the behavioral changes of CUMS, the expression of corticosterone (CORT) of the hypothalamo–pituitary–adrenal (HPA) axis, the expression of Glu-NMDA receptor and astrocytes glial fibrillary acidic protein (GFAP) in the hippocampus. We also investigated whether these changes were linked to XYS.<strong>Methods:</strong> 80 adult SD rats were randomly divided into four groups, control group, CUMS group, XYS group, and fluoxetine group. The rats in the control group and the CUMS group received 0.5 ml of deionized water once a day by intragastrically administration. Rats in the two treatment groups received XYS (2.224g/kg/d) and fluoxetine (2.0mg/kg/d) once a day, respectively. Rat hippocampus GFAP and Glu-NMDA receptor were respectively detected by real-time fluorescent quantitative PCR and western blot. The CORT of HPA axis was detected by Elisa. Body weight, food intake, and behavioral tests, such as open field tests, the sucrose preference test, and exhaustive swimming test, were used to assess depressive-like behavior in rats.<strong>Results:</strong> In this work, significant behavioral changes and differences in expression of the CORT of HPA axis and hippocampal GFAP and Glu-NMDA receptor were presented in CUMS-exposed rats. Like fluoxetine, XYS improved CUMS-induced rat's body weight, food intake, and depressive-like behavior. The study also proved that XYS could reverse the CUMS-induced changes of the CORT of HPA axis and affect the astrocytic activities and down-regulate the NR2B subunit of NMDA receptor (NR2B) level in the hippocampus.<strong>Conclusion:</strong> Changes in the hippocampus GFAP and Glu-NMDA receptor may be an essential mechanism of depression. Besides, XYS may be critical to the treatment of depression by intervention the HPA axis, GFAP and Glu-NMDA receptor.</span>
psychiatry
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the effect of Xiaoyaosan (XYS) on chronic unpredictable mild stress (CUMS) -induced depressive -like behaviors in rats and its mechanism. Specifically, the study aims to explore the role of XYS in the treatment of depression by regulating astrocyte activity induced by the hypothalamic -pituitary -adrenal axis (HPA axis). ### Research Background Depression is a common mental health problem, and chronic stress is considered one of the important risk factors for depression. Astrocytes are widely distributed in the central nervous system, and recent studies have found that they play an important role in the occurrence and development of neuropsychiatric diseases. In addition, the change in the expression of glial fibrillary acidic protein (GFAP), an astrocyte -specific cytoskeletal protein, is related to depression. Xiaoyaosan is a traditional Chinese medicine compound, which has been widely used in clinical and experimental studies of depression, but its specific mechanism is not yet fully understood. ### Research Objectives 1. **Establish a CUMS rat model**: Establish a rat model of depression by the CUMS method. 2. **Observe the regulatory effect of XYS**: Study the effects of XYS on the behavioral changes of CUMS rats, the expression of corticosterone (CORT) in the HPA axis, and the expressions of glutamate NMDA receptor (Glu - NMDA receptor) and GFAP in the hippocampus. 3. **Explore the mechanism**: Explore whether XYS improves the depressive -like behaviors of CUMS rats by regulating the HPA axis, GFAP and Glu - NMDA receptor. ### Methods - **Animal model**: 80 male Sprague Dawley (SD) rats were randomly divided into four groups: control group, CUMS group, XYS group and fluoxetine group. - **Drug treatment**: The control group and the CUMS group were given deionized water daily, and the XYS group and the fluoxetine group were given XYS and fluoxetine respectively. - **Behavioral tests**: Including sucrose preference test (SPT), forced swimming test (FST) and open field test (OFT). - **Sample collection and analysis**: Detect the serum CORT level, glutamate content in the hippocampus, mRNA and protein expressions of GFAP and NR2B. ### Results - **XYS improved the body weight and food intake of CUMS rats**. - **XYS improved the depressive -like behaviors of CUMS rats**, as shown in the SPT, FST and OFT tests. - **XYS decreased the serum CORT level and glutamate content in the hippocampus of CUMS rats**. - **XYS up - regulated the expression of GFAP and down - regulated the expression of NR2B in the hippocampus of CUMS rats**. ### Conclusion The results of this study indicate that the changes in GFAP and Glu - NMDA receptor in the hippocampus may be an important mechanism of depression, and Xiaoyaosan may treat depression by interfering with the HPA axis, GFAP and Glu - NMDA receptor.